President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget
In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online
News Analysis: IOM Report A Case Study In Communications Disaster
NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program
Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification
In Brief: Online Genetics Glossary; ORI Misconduct Finding
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?